MedTrace Logo

Study Watch AF Detection At Home

NCT04546763 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 117

Last updated 2021-10-06

No results posted yet for this study

Summary

This is a multi-center, prospective, non-randomized study to evaluate the performance of the study watch PPG algorithm in detecting irregular rhythms suggestive of atrial fibrillation (AF) in subjects at risk of having an event of AF in the free living (home) environment.

Conditions

Interventions

DEVICE

Study Watch

The Study Watch is a miniaturized wearable device made with biocompatible contact materials containing various sensors capable of measuring physiological and environmental metrics.

DEVICE

Zio XT

The Zio XT Patch, the reference device, is a FDA-cleared single-patient use, continuously recording ECG monitor that can be worn up to 14 days.

Sponsors & Collaborators

  • Verily Life Sciences LLC

    lead INDUSTRY

Principal Investigators

  • Hamid Ghanbari · Verily Life Sciences

Eligibility

Min Age
22 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-03
Primary Completion
2021-05-14
Completion
2021-05-14
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04546763 on ClinicalTrials.gov